Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

• Research unit: INNOSUISSE
• Project number: 19305.1 PFLS-LS

Short description (German)

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Short description (English)

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Abstract (German)

Qvanteq AG (Zurich, Switzerland; ETH Spinoff) has developped a proprietary coating-free surface technology for vascular stents (small metal mesh tubes, implanted into blood vessels to restore blood flow). The anti-thrombotic properties of a surface-treated stent promisses clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti-coagulant drug therapies and cumbersome re-interventions

Abstract (English)

Qvanteq AG (Zurich, Switzerland; ETH Spinoff) has developped a proprietary coating-free surface technology for vascular stents (small metal mesh tubes, implanted into blood vessels to restore blood flow). The anti-thrombotic properties of a surface-treated stent promisses clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti-coagulant drug therapies and cumbersome re-interventions